Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?
12:07pm, Tuesday, 16'th Dec 2025
The Dow Jones tracks 30 of the largest American companies across different sectors. Verizon, Chevron, and Merck hold the highest dividend yields in the Dow Jones.
Eli Lilly or Merck: Where Should Investors Put Their Money?
10:46am, Tuesday, 16'th Dec 2025
LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.
Cardinal Capital Management Inc. Buys 24,204 Shares of Merck & Co., Inc. $MRK
07:08am, Tuesday, 16'th Dec 2025
Cardinal Capital Management Inc. raised its stake in Merck and Co., Inc. (NYSE: MRK) by 9.0% during the undefined quarter, according to the company in its most recent 13F filing with the Securities an
GAMMA Investing LLC Has $5.78 Million Stake in Merck & Co., Inc. $MRK
05:44am, Tuesday, 16'th Dec 2025
GAMMA Investing LLC raised its position in shares of Merck and Co., Inc. (NYSE: MRK) by 19.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities a
MRK Gets Positive CHMP Opinion for Expanded Use of Winrevair in PAH
10:51am, Monday, 15'th Dec 2025
Merck secures a positive CHMP opinion to expand Winrevair's PAH use, potentially broadening treatment to adult patients across WHO FC II-IV.
Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC
08:04am, Monday, 15'th Dec 2025
Corient Private Wealth LLC increased its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 85.6% in the undefined quarter, according to the company in its most recent filing with the Securities an
Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK
06:46am, Monday, 15'th Dec 2025
Cullen Capital Management LLC grew its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 1.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commis
Caxton Associates LLP Increases Stake in Merck & Co., Inc. $MRK
06:46am, Monday, 15'th Dec 2025
Caxton Associates LLP grew its holdings in Merck and Co., Inc. (NYSE: MRK) by 23.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)
06:12am, Monday, 15'th Dec 2025
Representative Julie Johnson (D-Texas) recently sold shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on December 11th, the Representative disclosed that they had sold between $1,001 a
Caldwell Trust Co Purchases Shares of 48,103 Merck & Co., Inc. $MRK
03:53am, Monday, 15'th Dec 2025
Caldwell Trust Co acquired a new stake in Merck and Co., Inc. (NYSE: MRK) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acqui
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead?
03:27pm, Sunday, 14'th Dec 2025
Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their
Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake
10:10am, Saturday, 13'th Dec 2025
The rapid rise of artificial intelligence (AI) has transformed the stock market in recent years, powering massive gains in technology giants and growth-oriented investments. At the same time, dividend
AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK
06:36am, Saturday, 13'th Dec 2025
AQR Capital Management LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 13.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
12:23pm, Friday, 12'th Dec 2025
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.
Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?
11:05am, Friday, 12'th Dec 2025
Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.
